A Factorial Randomized Clinical Trial of Nicotine Replacement Therapy and Treatment Recommendations to Quit Versus Continue E-cigarettes When Quitting Smoking in Young Adult Dual Users
Nicotine and Tobacco Research · 2025
DOI: 10.1093/ntr/ntaf119 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nicotine and Tobacco Research, 2025. Verfasst von Elias M Klemperer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, College of Medicine, University of Vermont, Burlington, VT, USA. Hauptthemen laut MEDLINE: Smoking Cessation, Electronic Nicotine Delivery Systems, Tobacco Use Cessation Devices. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIDA NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Introduction
Multiple tobacco product use has increased markedly in the United States, especially dual use of cigarettes and e-cigarettes among young adults. Little is known regarding nicotine replacement therapy (NRT) for young adult dual users, or whether to recommend quitting versus continuing e-cigarettes during smoking cessation treatment.
Methods
This 2 × 2 factorial trial randomized 396 young adult dual users (aged 18–29; ≥ 5 cigarettes/day; used e-cigarettes on ≥ 10 of past 30 days) to receive 12 weeks of combination NRT versus No NRT to quit smoking, plus text-based treatment recommendations to Quit versus Continue E-cigarettes. The primary outcome was self-reported end-of-treatment 7-day point-prevalence abstinence (PPA) from cigarettes; a secondary outcome was end-of-treatment 30-day PPA from cigarettes.
Results
Participants were 26.0 (SD = 6.8) years old, 52.8% female, and 26.5% non-white. At week 12, NRT increased 7-day PPA (NRT = 50.5% versus No NRT = 39.9%; OR = 1.54, 95% CI = 1.03, 2.29), but neither treatment recommendation (Quit E-cigarettes = 48.0% versus Continue E-cigarettes = 42.4%; OR = 1.25, 95% CI = 0.84, 1.85) nor the NRT-by-treatment recommendation interaction were significant. The direction and magnitude of main effects for 30-day PPA at week 12 were similar to 7-day PPA, but the NRT-by-treatment recommendation interaction was significant (p = .04): smoking cessation was greatest for the NRT plus Quit E-cigarettes condition (47.1%) versus NRT plus Continue E-cigarettes (28.1%); No NRT plus Quit E-cigarettes (29.2%); and No NRT plus Continue E-cigarettes (30.4%) conditions (all p < .05).
Conclusions
NRT is effective in promoting early smoking cessation among young adult dual users. Secondary findings indicate that pairing NRT with support to quit both products could enhance the effects on prolonged cigarette abstinence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Psychiatry, College of Medicine, University of Vermont, Burlington, VT, USA.
- Department of Psychological Science, College of Arts and Sciences, University of Vermont, Burlington, VT, USA.
- Rutgers Institute for Nicotine & Tobacco Studies Rutgers Health, Department of Health Behavior, Society & Policy, Rutgers School of Public Health, New Brunswick, NJ, USA.
- Department of Psychiatry & Behavioral Sciences, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.
- Department of Biostatistics, University of Vermont, Burlington, VT, USA.
ORCID-Profile: Elias M Klemperer, Andrea C Villanti, Matthew J Carpenter
Förderung
- NIGMS NIH HHS
- NIDA NIH HHS
- NCI NIH HHS
- National Institute of General Medical Sciences
- U.S. Food and Drug Administration
- National Institute on Drug Abuse
- National Cancer Institute
Zitieren
APA
Klemperer, E. M., Feinstein, M. J. P., Marsh, K., Villanti, A. C., Carpenter, M. J., Skelly, J. M., DeSarno, M. J., & Higgins, S. T. (2025). A Factorial Randomized Clinical Trial of Nicotine Replacement Therapy and Treatment Recommendations to Quit Versus Continue E-cigarettes When Quitting Smoking in Young Adult Dual Users. Nicotine and Tobacco Research. https://doi.org/10.1093/ntr/ntaf119
Vancouver
Klemperer EM, Feinstein MJP, Marsh K, Villanti AC, Carpenter MJ, Skelly JM, et al. A Factorial Randomized Clinical Trial of Nicotine Replacement Therapy and Treatment Recommendations to Quit Versus Continue E-cigarettes When Quitting Smoking in Young Adult Dual Users. Nicotine and Tobacco Research. 2025. doi:10.1093/ntr/ntaf119
BibTeX
@article{Klemperer2025,
author = {Klemperer, Elias M and Feinstein, Marc Jerome P and Marsh, Katya and Villanti, Andrea C and Carpenter, Matthew J and Skelly, Joan M and DeSarno, Michael J and Higgins, Stephen T},
title = {A Factorial Randomized Clinical Trial of Nicotine Replacement Therapy and Treatment Recommendations to Quit Versus Continue E-cigarettes When Quitting Smoking in Young Adult Dual Users},
journal = {Nicotine and Tobacco Research},
year = {2025},
doi = {10.1093/ntr/ntaf119}
}
EUVIMED